Home » Gamajet Changes Product Name to Aseptic-1
Gamajet Changes Product Name to Aseptic-1
PharmaManufacturing.com
01/08/2010
Dan Meyer the current chairman of 3-A recently placed a congratulatory call to Gamajet Cleaning Systems on their latest authorization of the 3-A symbol for their once named, Gamajet IIIA. This rotary impingement tank-cleaning device is the first ever to receive such authorization. Chairman Meyer’s one concern was that the name itself might cause confusion amongst buyers, being as it is so closely related to the 3-A organization’s name. In compliance, Gamajet changed the product’s name from Gamajet IIIA to Aseptic-1.
The Aseptic-1 is an automated tank cleaning device, designed for permanent installation and to provide true germ and bacteria-free cleaning. Like all Gamajet machinces, the Aseptic-1 utilizes Gamajet’s patented rotary impingement process. This cleaning process is often more efficient than other processes but mechanically did not adhere to 3-A standards on its own. Gamajets engineers were able to alter the mechanical design while maintaining the main operating principles to not only meet but exceed most sanitary standards. This breakthrough in technology amazed regulatory officials. With nothing else like it, this remarkable Aseptic-1 stands to revolutionize the tank cleaning processes in sanitary environments. To more about Gamajet’s sanitary line, visit Gamajet's website at www.gamajet.com.
More News:
-
06/18/2013
Aragon Purchased For $650M+From USA Today
Johnson & Johnson has agreed to buy Aragon Pharmaceuticals for at least $650 million in cash.
-
06/18/2013
ASME BPE Certifies MaxPure Stainless-Steel Fittings
TEK Stainless Piping Products announces certification of MaxPure, EGMO’S stainless-steel fitting product line for bioprocessing industry
-
06/18/2013
Supreme Court Rules Against 'pay-to-delay'From Economic Times
Big pharma companies lose in Supreme Court's 'pay-to-delay' decision.
-
06/18/2013
BioScrip Acquires CarePoint for $223 MillionFrom Bloomberg Businessweek
BioScrip Inc. plans to expand its drug infusion business with a new acquisition of CarePoint for $223 million.
-
06/17/2013
Endress+Hauser Offers Online Thermowell Sizing Calculator
Free, online thermowell calculation tool compliant with new ASME PTC 19.3 TW-2010 standards simplifies engineer work
-
06/14/2013
Supreme Court DNA Ruling Could Hurt Biotech IndustryFrom The Denver Post Politics
Critics said the ruling would discourage other companies and financial backers from investing in more genetic sequencing research
-
06/14/2013
Supreme Court Says No to Patenting Human GenesFrom The Scientist
The Court unanimously ruled that isolated sequences of human DNA are not eligible for patent protection, but artificial sequences can be patented
-
06/13/2013
All-new Pharma EXPO Debuts in November 2014
Co-located with PACK-EXPO International, ISPE Pharma EXPO will be held in Chicago
-
06/13/2013
Canadian Health Authority Accepts Use of Roche's Rapid Mycoplasma Detection TestFrom Roche
Roche’s Rapid Mycoplasma Detection Test MycoTOOL Receives Acceptance from Canadian Authorities for Release Testing of Biopharmaceutical Roche Product
-
06/13/2013
Over 200 Cardiovascular Disease Drugs in DevelopmentFrom Drug Store News
According a recent report, 215 drugs are now under development for heart disease and stroke.
- All news »
Get Connected Now!
- Featured White Papers

Print page